Express News | Rigel Appoints Mark W. Frohlich, M.d. to Board of Directors
Press Release: Rigel Appoints Mark W. Frohlich, M.D. to Board of Directors
Rigel Pharmaceuticals, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Citi Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Raises Target Price to $55
Express News | Rigel Pharmaceuticals Inc : Citigroup Raises Target Price to $55 From $49
Rigel Pharmaceuticals Implements 1-for-10 Reverse Stock Split: Balancing Nasdaq Compliance and Investor Appeal
Rigel Pharmaceuticals Shares Are Trading Lower. The Company Reported Q4 Financial Results.
B.Riley Financial Maintains Rigel Pharmaceuticals(RIGL.US) With Hold Rating, Cuts Target Price to $24
B. Riley Raises Price Target on Rigel Pharmaceuticals to $24 From $20, Keeps Neutral Rating
Rigel Pharmaceuticals Analyst Ratings
Earnings Call Summary | Rigel Pharmaceuticals(RIGL.US) Q4 2024 Earnings Conference
Rigel Pharmaceuticals (RIGL) Surpasses Q4 Earnings and Revenue Estimates
Rigel Pharmaceuticals | 8-K: Rigel Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Rigel Pharmaceuticals | 10-K: FY2024 Annual Report
Express News | Rigel Pharmaceuticals Inc - 2025 Outlook: Revenue Approximately $200 to $210 Million
Express News | Rigel Pharmaceuticals Q4 EPS USD 0.81 Vs. IBES Estimate USD 0.47
Express News | Rigel Pharmaceuticals Q4 Net Income USD 14.3 Million Vs. IBES Estimate USD 8.56 Million
Rigel Pharmaceuticals 4Q Rev $57.6M >RIGL
Here Are the Major Earnings After the Close Today
Earnings Scheduled For March 4, 2025